MDRI research grant on dermatological pathologies
Objective
To support research on dermatological pathologies
Launch date
September 13, 2024
Budget and Funding
- The research grants awarded represent a maximum of $150,000 per investigator, or $50,000 per year over a maximum period of 3 years.
- Funds will be distributed annually on the date of the first funding installment.
- For the second and third years, renewal is conditional upon receipt of an annual report detailing the advancement of the research project, how the funds were spent in the previous year and the reason(s) supporting the continuation of the work.
Investigator Criteria and Conditions:
- The main affiliation of the investigator must be the dermatology service/department of the Université de Montréal or McGill University. If the investigator does not hold an academic position at the time of the grant application, a letter should be sent by the Dean of the faculty indicating the upcoming appointment and the date on which the new title will take effect.
- Must be a physician licensed to practice in Quebec (residents cannot apply as principal investigator).
- Cannot be an employee, contractor or consultant of Innovaderm Research Inc. or its affiliates.
- Must have the experience and/or expertise to lead the project.
- The principal investigator can only submit one application for funding as principal investigator and cannot be a co-investigator on another grant application to the MDRI.
- Grant application must be written in either English or French.
Grant Criteria and Conditions:
- The grant must focus on the prevention, diagnosis and/or treatment of a dermatological pathology.
- The research project must be conducted primarily at a university or a university-affiliated academic institution located in Montreal.
- A detailed budget in CAD on how the funds will be used must be presented with the application.
- Funds must only be used for the research project approved by MDRI.
- Funds may be used to pay for salary support for technicians and students, for animals and housing, reagents and lab consumables, and for travel and expenses related to the presentation of research results at a scientific meeting (limited to 2,500 CAD per year).
- Funds may NOT be used to pay for salary support of residents or fellows who are involved full-time or part-time in clinical activities with patients.
- The purchase of laboratory equipment may NOT exceed a total of $20,000 for the three-year grant period (aggregate of all laboratory equipment purchased with grant funds for the three-year period).
- Should there be any unused funds at the end of the three-year period, they must be returned to MDRI by the investigator/institution.
- Any transfer of the grant funds to another researcher, research project or institution must receive prior approval from MDRI.
- Three (3) months after the end of the funding period, the investigator and/or institution will need to certify in writing to MDRI that they have not used any funds to support their salary, the salary of a resident or a clinical research fellow, or to pay for indirect infrastructure research costs.
- Principal investigators, co-investigators and institutions are jointly responsible for ensuring that the guidelines and policies of the Canadian Council of Animal Care and the Tri-Council Policy Statement: Ethical Health Conduct of Research Involving Humans are followed, and that approvals from animal care and ethics committees are obtained, if required.
- MDRI must be recognized for its support in any presentation or publication related to, or as a result of, the research project.
- Investigator/institution must sign an agreement accepting all research grant criteria and conditions.
Important dates
Launch date | September 13, 2024 |
Application submission deadline | April 25, 2025, 5:00 PM |
Notification of selected candidate | August 2025 |
Application Process
Personal information provided in your application will be used solely for the purpose of treating your application for this grant.
Download, complete and sign the Application form and Investigator/Institution Agreement. You will be asked to upload these documents in the next step.
Provide (upload) the following supporting documents:
- Letter of introduction
- Research proposal:
- Include a clear description of the objectives, methods, expected results and any past related work.
- Indicate how the research is relevant to dermatology.
- Keep the length to no more than 10 pages including tables, figures and images (excluding references).
- Do not add copies of published, submitted or “in preparation” articles.
- Budget in CAD:
- Provide details on the three-year grant budget for reviewers to clearly understand how the funds will be spent; each line item must include a brief explanation.
- Provide information on current and awarded funding held by the principal investigator for all research activities.
- Curriculum Vitae:
- The principal investigator and co-investigator must submit a current CV in the format of a Canadian Common CV (CCV) www.ccv-cvc.ca
- Brief description of the principal investigator’s career plan.
- Signed Investigator/Institution Agreement.
Organize and format all documents according to the following requirements:
- The top right of each page must include the name of the principal investigator and the section title (e.g. “Letter of introduction”, “Research Proposal”, “Budget” ...).
- The bottom right of each page must include the page number.
- The document must have a 2.5 cm/1-inch margin width on all sides.
- The font must be black, 12 points (not condensed), with single line spacing.
- The digital documents must be formatted so that they can be printed on letter size paper (21.25 X 27.5 cm / 8.5 X 11 inches).
Submit your application!
An email acknowledging receipt will be sent for all completed applications. The system will not accept any uncompleted applications, or any applications received past the deadline date.
You can make donations here
Your donation to support dermatology research can make a tremendous difference in the lives of patients suffering from skin conditions.